Introduction: The coir industry processes fibers from coconuts and is important for a high number of people in Sri Lanka. Coir workers handle several dangerous machines. This project has studied occupational injuries among coir workers. Methods: This cross-sectional study was performed in six medium-sized coir industries in Sri Lanka, each with 15-100 employees. The workers who were present at work on the two days the researchers visited the respective industries (128 of total 214 workers) were interviewed on socio-demographics, work tasks they normally perform and occupational injuries they had experienced in the last three months. Independent T-tests and Chi-square tests were used to analyze for differences between groups. Results: The mean age of the 128 interviewed workers was 45 years and 53.9% were male. Totally 34 (26.6%) of the workers had experienced at least one injury each during the past three months. Women reported significantly more injuries than men (38.9% vs 15.9%). The workers operating machines reported significantly more injuries than workers who performed other types of work (42.3% vs 22.0%). Slipped, tripped, and fall (64%) were the most common events of injury seen among the injured workers followed by cuts by sharp objects or machines (20%). The most common type of injury among the workers reporting injuries were cuts and bruises (50%). Conclusion: More than one-fourth of the workers reported to have been injured in the last three months, indicating a high injury risk. This raises concerns and highlights the need for preventative measures to minimize risks.

Background Fibersol-2 has some beneficial effects on human health. We aimed to evaluate the digestive tolerability and acceptability of Fibersol-2 in healthy and diarrheal children, as well as improvement in stool consistencies in young diarrheal children. Methods Sixty children of either sex, aged 1–3 years having four groups (healthy children/low dose, healthy children/high dose, children with diarrhea/low dose and children with diarrhea/high dose) were enrolled into this exploratory study between 1st August to 23rd October 2017. Two presumptive doses, low (2.5g) and high (5g), twice daily with 50 ml drinking water for seven days were the interventions. Outcomes were to observe the development of possible abdominal symptoms, such as pain, distension, rumbling, and bloating during the intervention and post-intervention periods in healthy and diarrheal children as well as improvement in stool consistencies in diarrheal children. Results Among the diarrheal children, the median (IQR) duration of resolution of diarrhea was 3.9 (2.9, 5.1) days vs. 3.5 (2.0, 8.0) days, p = 0.885; in low dose and high dose groups, respectively. Significant difference was observed in terms of abdominal pain (27% vs. 7%, p = 0.038) and distension (40% vs. 0%, p<0.001) in diarrheal children, compared to healthy children during the pre-intervention period. We also observed significant difference in respect of abdominal distension (23% vs. 0%, p = 0.011), rumbling (27% vs. 0%, p = 0.005) and bloating (43% vs. 3%, p = 0.001) in diarrheal children, compared to healthy children during the intervention period. However, no significant difference was observed in relation to abdominal pain (p = 0.347) and distension (p = 0.165) during the pre-intervention period, compared to the intervention period in diarrheal children. Moreover, no significant difference was observed during the post-intervention period for the diarrheal and healthy children. Conclusion Fibersol-2 was found to be well tolerated in healthy and diarrheal children aged 1–3 years. Trial registration This study was registered as part of a randomized trial at ClinicalTrials.gov, number NCT03565393. The authors confirmed that all ongoing and related trials for this drug/intervention were registered.